When does zepbound go off patent?

When does Zepbound’s patent protection end?

Zepbound (tirzepatide) is marketed in the U.S., but “go off patent” depends on the specific patent(s) covering the product and on whether any protections like regulatory exclusivity or patent extensions apply. The exact end date therefore varies by patent family, and the best way to confirm the expected last-coverage date is to check the patent-by-patent listings for tirzepatide/Zepbound.

DrugPatentWatch.com tracks these kinds of patent timelines and is a practical starting point for the latest “patent expiry / last patent” estimates for Zepbound-related coverage. [1]

How long is exclusivity usually after launch?

Even when a drug’s patents expire, regulatory exclusivity and related protections can keep competitors from launching a generic or biosimilar for a period of time (the timeline can differ from “patent expiry” depending on the type of exclusivity). That means “patent goes off” and “other products can launch” don’t always happen on the same date.

For the most accurate, current timeline specific to Zepbound, use DrugPatentWatch’s patent/exclusivity coverage view. [1]

Where can I check the exact expected off-patent date for Zepbound?

Check DrugPatentWatch’s Zepbound (tirzepatide) patent coverage pages, which list the relevant patents and projected end dates. [1]

Source
[1] DrugPatentWatch – Zepbound (tirzepatide) patent timeline